Product News
Arch Biopartners Engages Cantox to Devise Drug Development Plan for GH501a
Drug development plan is expected to be complete by the end of 2011.
Product News
CureVac Presents Results of a Phase I/IIa Trial in NSCLC with CV9201 at SITC Meeting
High immune response rate of 84% in heavily pre-treated NSCLC patients.
Product News
Smart Cancer Diagnostics from Austria Impresses in Italy
tecnet supports successful sales partnership of Anagnostics.
Product News
Agilent Introduces CGH+SNP Cancer Microarrays and Cytogenomics Software for Cancer Research
Arrays based on designs by cancer cytogenomics microarray consortium.
Product News
Agilent Introduces CGH+SNP Cancer Microarrays and Cytogenomics Software for Cancer Research
Arrays based on designs by cancer cytogenomics microarray consortium.
Product News
First Patient Treated with RayStation® in the US
First cancer patient treated with RaySearch’s treatment planning system.
Product News
Cellceutix's Drug Discovery is a Major Leap Forward in the Fight Against Cancer
Drug delivery devices received from hospital and stability studies underway.
Product News
Critical Outcome Technologies Inc. Announces Definitive Proof of COTI-2’s Target and Single
COTI-2 is the first drug developed using the Company’s proprietary artificial intelligence system, CHEMSAS®.
Product News
SwissTrace Launches Twilite, an Innovative Product to Help in the Diagnosis Of Diseases, In Drug Development and Basic Research
A new and highly sensitive nuclear medicine blood sampler measures the time-course of radioactivity in whole blood.
Product News
PRECOS Partners with Reliable Cancer Therapies to Provide Rigorous Scientific Evidence for Complementary Cancer Medicines
PRECOS provide drug efficacy work to support RCT's research on complementary medicines.
Advertisement
